SOLATENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Solatene, and what generic alternatives are available?
Solatene is a drug marketed by Roche and is included in one NDA.
The generic ingredient in SOLATENE is beta carotene. There are two hundred and ten drug master file entries for this compound. Additional details are available on the beta carotene profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOLATENE?
- What are the global sales for SOLATENE?
- What is Average Wholesale Price for SOLATENE?
Summary for SOLATENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
DailyMed Link: | SOLATENE at DailyMed |
US Patents and Regulatory Information for SOLATENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | SOLATENE | beta carotene | CAPSULE;ORAL | 017589-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |